Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) EPS (Basic): 2012-2024

Historic EPS (Basic) for Neurogene (NGNE) over the last 11 years, with Dec 2024 value amounting to -$4.28.

  • Neurogene's EPS (Basic) rose 16.81% to -$0.99 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.11, marking a year-over-year decrease of 116.79%. This contributed to the annual value of -$4.28 for FY2024, which is 80.90% up from last year.
  • Neurogene's EPS (Basic) amounted to -$4.28 in FY2024, which was up 80.90% from -$22.41 recorded in FY2023.
  • In the past 5 years, Neurogene's EPS (Basic) registered a high of -$4.28 during FY2024, and its lowest value of -$139.88 during FY2022.
  • In the last 3 years, Neurogene's EPS (Basic) had a median value of -$22.41 in 2023 and averaged -$55.52.
  • Data for Neurogene's EPS (Basic) shows a peak YoY skyrocketed of 83.98% (in 2023) over the last 5 years.
  • Over the past 3 years, Neurogene's EPS (Basic) (Yearly) stood at -$139.88 in 2022, then skyrocketed by 83.98% to -$22.41 in 2023, then skyrocketed by 80.90% to -$4.28 in 2024.